Equillium, Inc. logo

Equillium, Inc. Dividend History (EQ)

  • 🤑 Equillium, Inc. has distributed a total of 12 dividends from 2006 to 2009

  • 📈 During this 3 period their dividend has seen a 37.50% increase in the payout amount

About Equillium, Inc.

Equillium, Inc. is a biotechnology company founded in 2017 by Krishna Polu, Bruce Steel, and Stephen Connelly. The company is headquartered in La Jolla, California, and focuses on developing innovative treatments for severe autoimmune and inflammatory diseases. Equillium's lead product candidate, itolizumab, is a monoclonal antibody designed to modulate the activity of the immune system and address conditions such as lupus nephritis, uncontrolled asthma, and more. As a clinical-stage biotech firm, Equillium collaborates with various research institutions to advance its pipeline and validate its therapeutic approaches. The company went public in 2018, trading on the Nasdaq under the ticker symbol EQ. While revenue streams are primarily research and development-based at this stage, Equillium's commitment to addressing unmet medical needs positions it as a promising player in the biotech industry.

Address: 2223 Avenida De La Playa, La Jolla, CA, 92037
Phone: (858) 412-5302

Previous Payouts (12)

The most recent dividend Equillium, Inc. paid out was on June 30, 2009 (5637 days ago) for $0.6875 per share

Pay DateAmount
June 30, 2009$0.6875
March 31, 2009$0.6875
December 31, 2008$0.6875
September 30, 2008$0.6875
June 30, 2008$0.6875
March 31, 2008$0.6875
December 31, 2007$0.625
September 30, 2007$0.625
June 30, 2007$0.625
March 31, 2007$0.5
December 31, 2006$0.5
September 30, 2006$0.5

Dividend data last updated Thu, 05 Dec 2024 17:40:45 GMT UTC